Lung cancer, Non small cell lung cancer (NSCLC)
Results
Pilot
This study was done to find out more about small pieces of genetic material () that cancer cells can release into the bloodstream. This is called circulating tumour DNA, or ctDNA.
The study was for people with stage 1, 2 or 3 non small cell lung cancer (NSCLC). They were due to have treatment aimed at curing their cancer.
It was open for people to join between 2015 and 2017. The team published the results in 2022
Recruitment start: 12 January 2015
Recruitment end: 30 April 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Nitzan Rosenfeld
Cancer Research UK
Cambridge University Hospitals NHS Foundation Trust
NIHR Clinical Research Network: Cancer
Sociedad Española de Oncología Médica
Last reviewed: 15 May 2023
CRUK internal database number: 13914
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
